[go: up one dir, main page]

BR9809589A - Uso de oligossacarìdios para o tratamento de tecidos conectivos - Google Patents

Uso de oligossacarìdios para o tratamento de tecidos conectivos

Info

Publication number
BR9809589A
BR9809589A BR9809589-7A BR9809589A BR9809589A BR 9809589 A BR9809589 A BR 9809589A BR 9809589 A BR9809589 A BR 9809589A BR 9809589 A BR9809589 A BR 9809589A
Authority
BR
Brazil
Prior art keywords
treatment
connective tissues
oligosaccharides
oligosaccharide
connective
Prior art date
Application number
BR9809589-7A
Other languages
English (en)
Inventor
Alexandre Michel Robert
Ladislas Robert
Dominique Castelli
Original Assignee
Johnson & Johnson Consumer Fr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Fr filed Critical Johnson & Johnson Consumer Fr
Publication of BR9809589A publication Critical patent/BR9809589A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)

Abstract

Patente de Invenção: <B>"USO DE OLIGOSSACARìDIOS PARA O TRATAMENTO DE TECIDOS CONECTIVOS"<D>. A presente invenção refere-se ao uso de pelo menos um oligossacarídio possuindo de 2 a 6 resíduos de glicosídio e tendo um resíduo de galactose em uma posição terminal de não-redução, ou de um derivado de tal oligossacarídio capaz de ser obtido pela ligação de um radical hidrofóbico, para a preparação de uma composição pretendida para aumentar a síntese e/ou diminuir a degradação dos proteoglicans do tecido conectivo.
BR9809589-7A 1997-05-02 1998-04-30 Uso de oligossacarìdios para o tratamento de tecidos conectivos BR9809589A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9705464A FR2762783B1 (fr) 1997-05-02 1997-05-02 Utilisation d'oligosaccharides pour le traitement du tissu conjonctif et methode de traitement cosmetique mettant en oeuvre ces oligosaccharides
PCT/IB1998/000657 WO1998050013A1 (en) 1997-05-02 1998-04-30 Use of oligosaccharides for the treatment of connective tissues

Publications (1)

Publication Number Publication Date
BR9809589A true BR9809589A (pt) 2000-07-04

Family

ID=9506552

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809589-7A BR9809589A (pt) 1997-05-02 1998-04-30 Uso de oligossacarìdios para o tratamento de tecidos conectivos

Country Status (11)

Country Link
EP (1) EP0979065A1 (pt)
JP (1) JP2001524122A (pt)
KR (1) KR20010012159A (pt)
AR (1) AR012642A1 (pt)
AU (1) AU6850098A (pt)
BR (1) BR9809589A (pt)
CA (1) CA2288773A1 (pt)
CO (1) CO4940384A1 (pt)
FR (1) FR2762783B1 (pt)
PL (1) PL336592A1 (pt)
WO (1) WO1998050013A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795956B1 (fr) * 1999-07-06 2006-07-14 Inst Evaluation Dermatophysiqu Composition cosmetique pour ameliorer l'elasticite de la peau et lutter contre son vieillissement
FR2811228B1 (fr) * 2000-07-07 2002-10-25 Lvmh Rech Utilisation d'oligosaccharides ou d'extraits de plantes en contenant comme agent cosmetique ou dermatologique notamment pour stimuler la production de beta-endorphine dans la peau
KR100839648B1 (ko) * 2008-03-04 2008-06-19 씨에이치디메딕스 주식회사 모근의 진피층 보강과 보습을 통한 탈모방지 조성물
GB2500585A (en) * 2012-03-23 2013-10-02 Univ Manchester Use of oligosaccharides to reduce skin pigmentation
WO2024150915A1 (ko) * 2023-01-11 2024-07-18 주식회사 풀바이오스 미세먼지로 인한 피부 손상 보호 및 탈모 방지용 조성물 및 그 제조방법
FR3152121A1 (fr) 2023-08-16 2025-02-21 Sederma Exopolysaccharide et oligosaccharides notamment pour la cosmétique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873085A (en) * 1987-04-20 1989-10-10 Fuisz Pharmaceutical Ltd. Spun fibrous cosmetic and method of use
FR2709061B1 (fr) * 1993-08-17 1996-07-19 Ladislas Robert Utilisation d'oligosaccharides dans la prévention et le traitement du vieillissement des tissus.
FR2730409B1 (fr) * 1995-02-15 1997-05-09 Dior Christian Parfums Utilisation des galactolipides, en particulier galactosylglycerides, et des extraits d'origine naturelle contenant ces produits, dans les domaines cosmetiques, pharmaceutique et notamment dermatologique
FR2739556B1 (fr) * 1995-10-04 1998-01-09 Oreal Utilisation de carbohydrates pour favoriser la desquamation de la peau

Also Published As

Publication number Publication date
WO1998050013A1 (en) 1998-11-12
JP2001524122A (ja) 2001-11-27
CA2288773A1 (en) 1998-11-12
FR2762783A1 (fr) 1998-11-06
CO4940384A1 (es) 2000-07-24
EP0979065A1 (en) 2000-02-16
FR2762783B1 (fr) 2002-09-13
AU6850098A (en) 1998-11-27
KR20010012159A (ko) 2001-02-15
PL336592A1 (en) 2000-07-03
AR012642A1 (es) 2000-11-08

Similar Documents

Publication Publication Date Title
TW283716B (pt)
HUP0001192A3 (en) The use of topiramate and its derivatives for the preparation of pharmaceutical compositions treating obesity
GB9717617D0 (en) Process for glucan preparation and therapeutic uses of glucan
CA2180950A1 (en) Kallikrein-inhibiting &#34;kunitz domain&#34; proteins and analogues thereof
CA2165740A1 (en) Anti-adhesion films and compositions for medical use
FI954654A0 (fi) Aminosokeri- ja glykosaminoglykaanikoostumus sidekudosvauroiden hoitoon ja korjaukseen
BG103438A (en) Improvements of or in relation to diagnostic/therapeutical forms
MY133027A (en) C-4&#34;-substituted macrolide derivatives
CA2316919A1 (en) Novel macrolides
EP1024145A3 (en) Novel azalides and methods of making same
BR9809951A (pt) Método para tratamento da obesidade
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
AU1212792A (en) Sulphated oligosaccharides for treatment of arteriosclerotic disorders and prevention of restenosis
GB2334446B (en) Aqueous compositions compromising a lipid and a lanolin-derived surfactant,and their use
AU699585B2 (en) Use of oligosaccharides in the prevention and treatment of the aging of tissues
CA2209696A1 (fr) Utilisation d&#39;un polyholoside dans une composition destinee a stimuler les defenses immunitaires, et composition le comprenant
BR9809589A (pt) Uso de oligossacarìdios para o tratamento de tecidos conectivos
BR0208924A (pt) Uso de conjugados de ácido graxo de sal biliar ou de ácido biliar
BR9710630A (pt) Uso de pelo menos um oligossacarìdeo, composição dermatocosmética, e, processo e tratamento cosmético de peles hiper-reativas.
AU3658793A (en) Bimodal molecular weight hyaluronate formulations and methods for using same
GR900100232A (en) Erythromycine derivatives
CA2337667A1 (en) Dextran-leptin conjugates, pharmaceutical compositions and related methods
HU913245D0 (en) Galacto-mannane derivatives for covering medically active agents
BR9811422A (pt) Processo para a inibição de hiperplasia celular de músculo liso vascular em um paciente humano ou em outro paciente animal de sangue quente necessitando de tal tratamento, uso de pelo menos um oligossacarìdeo sulfatado, e, composição farmacêutica ou veterinária para a inibição de hiperplasia celular de músculo liso vascular
BR9808216A (pt) Composição cosmética ou farmacêutica contendo pelo menos um retinóide

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired
B15K Others concerning applications: alteration of classification

Ipc: A61Q 17/00 (2006.01), A61K 8/60 (2006.0